Trials / Not Yet Recruiting
Not Yet RecruitingNCT05555225
Methylome Study in Sporadic Limb Malformations
Methylome Study in Patients Affected With Sporadic Limb Malformations
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Some limb malformations are known to be sporadic (non hereditary). For these malformations, no molecular cause was identified, even after whole genome sequencing. Methylation of CpG islands is an epigenetic process which is usually not transmitted to the descents. We hypothesize that sporadic limb malformations may be due to a methylation anomaly. This study will include patients with Amelia or Femur Fibula Ulna Syndrome. With patients consent, we will study the methylome on DNA samples already available in our laboratory. Each patient sample will be paired to a control of same tissue, age and sex. By bioinformatics comparison, we will identify differentially methylated candidate regions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Methylome | Epigenetic study : analysis of DNA methylation |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2022-09-26
- Last updated
- 2024-05-16
Source: ClinicalTrials.gov record NCT05555225. Inclusion in this directory is not an endorsement.